Anaptysbio (ANAB) EPS (Basic) Growth (1y) (2017 - 2026)
Anaptysbio (ANAB) EPS (Basic) Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 112.82% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | -43.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.62% |
| Dec 31, 2025 | 468.66% |
| Sep 30, 2025 | 147.76% |
| Jun 30, 2025 | 21.39% |
| Mar 31, 2025 | 21.71% |
| Dec 31, 2024 | 119.61% |
| Sep 30, 2024 | 19.10% |
| Jun 30, 2024 | -13.99% |
| Mar 31, 2024 | 26.74% |
| Dec 31, 2023 | -94.17% |
| Sep 30, 2023 | -5.68% |
| Jun 30, 2023 | 17.38% |
| Mar 31, 2023 | -10.00% |
| Dec 31, 2022 | 31.13% |
| Sep 30, 2022 | -8.31% |
| Jun 30, 2022 | -89.32% |
| Mar 31, 2022 | -57.36% |
| Dec 31, 2021 | -195.04% |
| Sep 30, 2021 | -41.11% |
| Jun 30, 2021 | -21.11% |